Cargando…

TROP2 methylation and expression in tamoxifen-resistant breast cancer

BACKGROUND: The DNA methyltransferase 1 inhibitor, 5-Aza-2′-deoxycytidine (5-Aza-dC) is a potential treatment for breast cancer. However, not all breast tumors will respond similarly to treatment with 5-Aza-dC, and little is known regarding the response of hormone-resistant breast cancers to 5-Aza-d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zimmers, Stephanie M., Browne, Eva P., Williams, Kristin E., Jawale, Rahul M., Otis, Christopher N., Schneider, Sallie S., Arcaro, Kathleen F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034260/ https://www.ncbi.nlm.nih.gov/pubmed/30002602 http://dx.doi.org/10.1186/s12935-018-0589-9

Ejemplares similares

ELF5 and DOK7 regulation in anti-estrogen treated cells and tumors
por: Fitzgerald, Lily M., et al.
Publicado: (2016)

Paralemmin-1 is over-expressed in estrogen-receptor positive breast cancers
por: Turk, Casey M, et al.
Publicado: (2012)

Enrichment of CpG island shore region hypermethylation in epigenetic breast field cancerization
por: Muse, Meghan E., et al.
Publicado: (2020)

Alteration of Trop-2 expression in breast cancer cells by clinically used therapeutic agents and acquired tamoxifen resistance
por: Zhu, Jing, et al.
Publicado: (2022)

Exosomes from tamoxifen-resistant breast cancer cells transmit drug resistance partly by delivering miR-9-5p
por: Liu, Jianhui, et al.
Publicado: (2021)

Down-regulation of sfrp1 in a mammary epithelial cell line promotes the development of a cd44(high)/cd24(low )population which is invasive and resistant to anoikis
por: Gauger, Kelly J, et al.
Publicado: (2009)

Activation of p53, inhibition of telomerase activity and induction of estrogen receptor beta are associated with the anti-growth effects of combination of ovarian hormones and retinoids in immortalized human mammary epithelial cells
por: Zhang, Jiahui, et al.
Publicado: (2005)

Clinicopathologic significance of TROP2 and phospho-TROP2 in gastric cancer
por: Kushiyama, Shuhei, et al.
Publicado: (2021)

Trop-2 Is a Determinant of Breast Cancer Survival
por: Ambrogi, Federico, et al.
Publicado: (2014)

Trop-2 as a Therapeutic Target in Breast Cancer
por: Sakach, Elizabeth, et al.
Publicado: (2022)

Introducing a low-risk breast screening pathway into the NHS Breast Screening Programme: Views from healthcare professionals who are delivering risk-stratified screening
por: Woof, Victoria G, et al.
Publicado: (2021)

Trop petits pour Dieu /
por: Laederach, Monique, 1938-
Publicado: (1986)

Une trop bruyante solitude/
por: Hrabal, Bohumil, 1914-1997
Publicado: (1983)

Une fin trop précoce?
por: Rayson, Daniel
Publicado: (2022)

Correction: Trop-2 Is a Determinant of Breast Cancer Survival
Publicado: (2014)

TROP2 as Patient-Tailoring but Not Prognostic Biomarker for Breast Cancer
por: Liu, Xiaoyue, et al.
Publicado: (2022)

DNMT1 facilitates growth of breast cancer by inducing MEG3 hyper-methylation
por: Zhu, Xiaotao, et al.
Publicado: (2022)

In vitro analysis of the invasive phenotype of SUM 149, an inflammatory breast cancer cell line
por: Hoffmeyer, Michaela R, et al.
Publicado: (2005)

Telehealth intervention for Latina breast cancer survivors: A pilot
por: Meneses, Karen, et al.
Publicado: (2018)

Tamoxifen Resistance in Breast Cancer
por: Chang, Minsun
Publicado: (2012)

Comparison of characteristics in Mexican women with breast cancer according to healthcare coverage
por: Martinez-Cannon, Bertha Alejandra, et al.
Publicado: (2020)

Health system experiences of breast cancer survivors in urban South Africa
por: Lambert, Madeleine, et al.
Publicado: (2020)

The implications of women’s activity limitations and role disruptions during breast cancer survivorship
por: Keesing, Sharon, et al.
Publicado: (2018)

Resuming Sensitivity of Tamoxifen-Resistant Breast Cancer Cells to Tamoxifen by Tetrandrine
por: Wang, Yuntao, et al.
Publicado: (2021)

The relationship between breast size and aspects of health and psychological wellbeing in mature-aged women
por: Spencer, Linda, et al.
Publicado: (2020)

Prediagnostic breast milk DNA methylation alterations in women who develop breast cancer
por: Salas, Lucas A, et al.
Publicado: (2020)

Changes in DNA methylation are associated with the development of drug resistance in cervical cancer cells
por: Chen, Chih-Cheng, et al.
Publicado: (2015)

“I never heard anything about it”: Knowledge and psychosocial needs of Latina breast cancer survivors with lymphedema
por: Buki, Lydia P, et al.
Publicado: (2021)

Identification and characterization of methylation-mediated transcriptional dysregulation dictate methylation roles in preeclampsia
por: Zhao, Shuyu, et al.
Publicado: (2020)

The impact of high-risk and chronic opioid use among commercially insured endometriosis patients on health care resource utilization and costs in the United States
por: Estes, Stephanie J, et al.
Publicado: (2020)

Decoding TROP2 in breast cancer: significance, clinical implications, and therapeutic advancements
por: Yao, Liqin, et al.
Publicado: (2023)

Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer
por: Sperger, Jamie M., et al.
Publicado: (2023)

Trop-2 in Upper Tract Urothelial Carcinoma
por: Tomiyama, Eisuke, et al.
Publicado: (2022)

Predictive biomarkers for sacituzumab govitecan efficacy in Trop-2-expressing triple-negative breast cancer
por: Cardillo, Thomas M., et al.
Publicado: (2020)

Integrative DNA methylation and gene expression analysis to assess the universality of the CpG island methylator phenotype
por: Moarii, Matahi, et al.
Publicado: (2015)

Oncogenic transformation of mammary epithelial cells by transforming growth factor beta independent of mammary stem cell regulation
por: Dunphy, Karen A, et al.
Publicado: (2013)

Uterine and ovarian carcinosarcomas overexpressing Trop-2 are sensitive to hRS7, a humanized anti-Trop-2 antibody
por: Raji, Rhoda, et al.
Publicado: (2011)

Epigenetically upregulating TROP2 and SLFN11 enhances therapeutic efficacy of TROP2 antibody drug conjugate sacitizumab govitecan
por: Zhao, Ming, et al.
Publicado: (2023)

DNA methylation biomarkers for hepatocellular carcinoma
por: Fan, Guorun, et al.
Publicado: (2018)

Molecular prediction of tamoxifen resistance in breast cancer
por: Kok, M, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_ce0ociec9pc35cjtv79ptfkdto